GoodRx vs Ekho
Side-by-side comparison of AI visibility scores, market position, and capabilities
NASDAQ-listed (GDRX) prescription savings platform comparing prices across 70K+ pharmacies; $750M revenue with stock under pressure from Amazon Pharmacy and Cost Plus Drugs competition.
About
GoodRx is a Santa Monica-based prescription savings and healthcare price comparison platform that enables consumers to compare prices, access discount coupons, and find the lowest-cost pharmacy for their prescriptions — providing free price comparison tools across 70,000+ US pharmacies and a GoodRx Gold subscription ($9.99/month) with even lower prices on 1,000+ common medications. Listed on NASDAQ (NASDAQ: GDRX), GoodRx went public in September 2020 and generates approximately $750 million in annual revenue primarily from pharmaceutical industry fees and consumer subscription revenue.
End-to-end vehicle commerce platform automating titling, registration, and compliance for OEM national sales; $17.3M from Activant, JPMorgan Payments, and Winnebago with 20+ OEM customers.
About
Ekho is an end-to-end vehicle commerce platform that provides digital sales infrastructure for automotive dealers and OEMs — handling the complete transaction lifecycle for nationwide vehicle sales including digital checkout, financing integration, titling, registration, and compliance management for vehicles sold across state lines. Founded and backed by Y Combinator, Activant Capital, JPMorgan Payments, and Winnebago Industries, Ekho raised $17.3 million total including a $15 million Series A, serving 20+ OEM customers including four publicly traded manufacturers.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.